This edition first published 2020
© 2020 John Wiley & Sons Ltd.
All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, except as permitted by law. Advice on how to obtain permission to reuse material from this title is available at http://www.wiley.com/go/permissions.
The right of Hiroshi Ashihara, Iziar A. Ludwig and Alan Crozier to be identified as the author(s) of this work has been asserted in accordance with law.
Registered Office(s)
John Wiley & Sons Ltd, The Atrium, Southern Gate, Chichester, West Sussex, PO19 8SQ, UK
Editorial Office
9600 Garsington Road, Oxford, OX4 2DQ, UK
For details of our global editorial offices, customer services, and more information about Wiley products visit us at www.wiley.com.
Wiley also publishes its books in a variety of electronic formats and by print-on-demand. Some content that appears in standard print versions of this book may not be available in other formats.
Limit of Liability/Disclaimer of Warranty
While the publisher and authors have used their best efforts in preparing this work, they make no representations or warranties with respect to the accuracy or completeness of the contents of this work and specifically disclaim all warranties, including without limitation any implied warranties of merchantability or fitness for a particular purpose. No warranty may be created or extended by sales representatives, written sales materials or promotional statements for this work. The fact that an organization, website, or product is referred to in this work as a citation and/or potential source of further information does not mean that the publisher and authors endorse the information or services the organization, website, or product may provide or recommendations it may make. This work is sold with the understanding that the publisher is not engaged in rendering professional services. The advice and strategies contained herein may not be suitable for your situation. You should consult with a specialist where appropriate. Further, readers should be aware that websites listed in this work may have changed or disappeared between when this work was written and when it is read. Neither the publisher nor authors shall be liable for any loss of profit or any other commercial damages, including but not limited to special, incidental, consequential, or other damages.
Library of Congress Cataloging-in-Publication Data
Name: Ashihara, Hiroshi, author.
Title: Plant nucleotide metabolism : biosynthesis, degradation, and alkaloid formation / Hiroshi Ashihara, Emeritus Professor, Ochanomizu University, Tokyo, Japan, Iziar A. Ludwig, University Rovira I, Virgili, Spain, Alan Crozier, University of California, Davis and University of Glasgow, UK.
Description: First edition. | Hoboken : Wiley, 2020. | Includes bibliographical references and index.
Identifiers: LCCN 2019047672 (print) | LCCN 2019047673 (ebook) | ISBN 9781119476122 (hardback) | ISBN 9781119476108 (adobe pdf) | ISBN 9781119476078 (epub)
Subjects: LCSH: Plants–Metabolism. | Nucleotides–Metabolism.
Classification: LCC QK881 .A74 2020 (print) | LCC QK881 (ebook) | DDC 572/.42–dc23
LC record available at https://lccn.loc.gov/2019047672
LC ebook record available at https://lccn.loc.gov/2019047673
Cover Design: Wiley
Cover Image: © Mazur Travel/Shutterstock
Almost all organisms produce nucleobases, nucleosides and nucleotides of purines and pyrimidines. There have been a number of books on nucleotide metabolism in microorganisms and humans. However, this is the first to focus on plants which exhibit important differences to other organisms in key areas of nucleotide metabolism and function.
The book covers the metabolism of purine, pyrimidine and pyridine nucleotides and nucleotide alkaloids in higher plants and points out differences from that occurring in other organisms. Likewise, differences in the salvage pathways and diversity of interconversions in plants, fungi and bacteria are highlighted. Various physiological aspects of these processes are covered along with their involvement in the control of plant growth and development. Among the topics covered are the purine alkaloids caffeine, theobromine and their metabolites which, in species including coffee, tea and cocoa, accumulate in quantity. There is also discussion of the function of purine alkaloids and the potential allelopathic role of caffeine. Studies, some making use of genetically-modified plants, have indicated that caffeine can play a role in a variety of plant defence strategies. Other investigations have provided evidence that trigonelline, found principally in coffee and legumes, has a role in resistance to salt stress and can act as a natural pesticide to reduce insect infestations. Finally, the book explores the absorption, metabolism and potential impact on health of dietary caffeine, theobromine and trigonelline
The book provides comprehensive information on nucleotide structures and metabolic pathways and is a unique resource on a diversity of topics and as such is essential reading for students, researchers, and lecturers in plant biochemistry, physiology, chemistry, agricultural sciences, nutrition and the associated applied fields of research.
We owe special thanks Professors Tatsuhito Fujimura, Claudio Stasolla and Takao Yokota for their help with some of the figures and advice on genes encoding key enzymes and chemical structures for the book.
Hiroshi Ashihara
Iziar A. Ludwig
Alan Crozier
The chemistry of purine, pyrimidine, and pyridine nucleobases, nucleosides, and nucleotides constitute one of the oldest topics in biochemistry. In this chapter, the nomenclature and structures of nucleotides are briefly described.
The nucleotide nomenclature and abbreviations employed in the text are those used by Henderson and Paterson (1973) in their textbook ‘Nucleotide Metabolism – An Introduction’. The terms ‘nucleoside’ and ‘nucleotide’ in the strictest sense refer, respectively, to N-glycosides and phosphorylated N-glycosides derived from nucleic acids. However, they are now used in a wider context. N-Ribosides, such as nicotinamide mononucleotide (NMN), are called nucleotides only by extension and analogy, and nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP) are referred to as dinucleotides. Flavin mononucleotide (FMN) is a step further removed, as it contains ribitol, a pentose alcohol formed by the reduction of ribose, instead of ribose, while flavin adenine dinucleotide (FAD) similarly extends the meaning of dinucleotide. N-Glycosides such as orotidine 5′-monophosphate (OMP) and adenylosuccinate (SAMP) are called nucleotides through their close relationship to the ‘true’ nucleotides. The terms ribonucleoside and ribonucleotide are used in preference to riboside and ribotides. The IUPAC-IUB Combined Commission on Biochemical Nomenclature has abbreviations and symbols for nucleotides and related compounds. However, as argued by Henderson and Paterson (1973), while they are appropriate for polynucleotides, the distinction between bases and nucleosides is not always immediately obvious, and this has limited their use. The abbreviations used here are more intuitive and better suited to the portrayal of reaction schemes in which the addition or removal of substituent groups occurs.
In Table 1.1, the abbreviations for the major nucleotides, ribo- and deoxyribonucleotides and nucleobases are presented. For readers convenience, the styles used both in this book (style #1) and those recommended by IUPAC (style #2) are shown.
Table 1.1 Nomenclature and abbreviations of purine and pyridine ribo- and deoxyribonucleotides and related compounds.
Ribonucleotides | Ribonucleosides | #1 | #2 | Nucleobases | #1 | #2 | |
Adenosine-5′-monophosphate | AMP | Adenosine | AR | Ado | Adenine | A | Ade |
Guanosine-5′-monophosphate | GMP | Guanosine | GR | Guo | Guanine | G | Gua |
Inosine-5′-monophosphate | IMP | Inosine | IR | Ino | Hypoxanthine | H | Hyp |
Xanthosine-5′-monophosphate | XMP | Xanthosine | XR | Xao | Xanthine | X | Xan |
Uridine-5′-monophosphate | UMP | Uridine | UR | Urd | Uracil | U | Ura |
Cytidine-5′-monophosphate | CMP | Cytidine | CR | Cyd | Cytosine | C | Cyt |
Orotidine-5′-monophosphate | OMP | Orotidine | OR | Ord | Orotic acid | O | Oro |
Deoxyribonucleotides | Deoxyribonucleosides | #1 | #2 | Nucleobases | #1 | #2 | |
Deoxyadenosine-5′-monophosphate | dAMP | Deoxyadenosine | AdR | dAdo | Adenine | A | Ade |
Deoxyguanosine-5′-monophosphate | dGMP | Deoxyguanosine | GdR | dGuo | Guanine | G | Gua |
Deoxyuridine-5′-monophosphate | dUMP | Deoxyuridine | UdR | dUrd | Uracil | U | Ura |
Deoxycytidine-5′-monophosphate | dCMP | Deoxycytidine | CdR | dCyd | Cytosine | C | Cyt |
Thymidine-5′-monophosphate | dTMP | Thymidine | TdR | dThd | Thymine | T | Thy |
Two types of symbols are used for nucleoside and nucleobases. Style #1: recommended in Nucleotide Metabolism (Henderson and Paterson 1973). Style #2: recommended by the IUPAC-IUB Commission on Biochemical Nomenclature (1970). In this book, style #1 is adopted.
Abbreviations for ribonucleosides and 2-deoxyribonucleosides are derived from those used for the bases plus those for the ribosyl or 2′-deoxyribosyl groups. Thus AR stands for adenosine and AdR is the abbreviation for deoxyadenosine. In the case of inosine, (hypoxanthine + ribose) HR may be possible, but IR is often used. The latter is used in this text.
For nucleotides, the traditional abbreviations based on the term ‘nucleoside monophosphate’ are used. Thus AMP stands for adenosine monophosphate (adenylate), UMP for uridine monophosphate (uridylate), and NMP for any ribonucleoside monophosphate. Similarly, dAMP stands for deoxyadenosine monophosphate (deoxyadenylate), dUMP for deoxyuridine monophosphate (deoxyuridylate), and dNMP for any deoxyribonucleoside monophosphate. Thymidine monophosphate (thymidylate) often does not have the ‘deoxy’ prefix in its name, because thymidine is thymine deoxyriboside. However, the symbol including a ‘d’ is commonly used in biochemistry textbooks, so dTMP is adopted in this article.
Studies on purines and pyrimidines began in 1776 when the Swedish pharmacist Carl Wilhelm Scheele isolated uric acid from bladder stones. In 1846, Unger isolated guanine from the guano of Peruvian sea birds. At the end of the nineteenth century, several purines (adenine, xanthine, and hypoxanthine) and pyrimidines (thymine, cytosine, and uracil) were discovered by the German biochemist, Albrecht Kossel who believed they constituted the main part of cell nuclei. In 1874 Friedrich Miescher isolated nuclear material rich in phosphorus which he called ‘nuclein’. In the same period, Emil Fischer (1884) elucidated the structures of caffeine and related compounds which he confirmed by chemical synthesis. Further information can be found in a historical survey by Burnstock and Verkhratsky (2012). The pyridine nucleotide, NAD was discovered by the British biochemists Arthur Harden and William John Young in the early twentieth century (Harden and Young 1906).
A purine is a heterocyclic compound that consists of a pyrimidine ring fused to an imidazole ring. The word, ‘purine’ (‘Purum’ + ‘Uricum’) was coined by Emil Fischer (1884).
As shown in structure 1 the atoms of the purine ring are numbered in an anticlockwise manner. In plants, there are several naturally occurring purine bases. They include adenine (2) and guanine (3), which are constituents of nucleic acids, and hypoxanthine (4), xanthine (5), and uric acid (6), which are produced as catabolites of adenine and guanine. Purine alkaloids, such as theobromine (3,7-dimethylxanthine) (7), theophylline (1,3-dimethylxanthine) (8), caffeine (1,3,7-trimethylxanthine) (9), and theacrine (1,3,7,9-tetramethyluric acid) (10) are derived from purine nucleotides, as are the major cytokinin plant hormones isopentenyladenine (11), benzyladenine (12), and trans-zeatin (13) (Ashihara et al. 2013).
A nucleoside consists of a nucleobase and a five-carbon sugar (ribose or deoxyribose). Adenosine (14), guanosine (15), inosine (16), and xanthosine (17) are catabolites of purine ribonucleotides and RNA while deoxyadenosine (18) and deoxyguanosine (19) are catabolites of DNA. Cytokinins also occur as ribosides, namely, isopentenyladenine riboside (20), benzyladenine riboside (21), and trans-zeatin riboside (22) (Ashihara et al. 2013).
A nucleotide is composed of a purine base, a sugar moiety (ribose or deoxyribose) and at least one phosphate group. The phosphate group is attached to either the C3′or C5′ position of the sugar. Nucleoside-5′-phosphates (5′-nucleotides) are the main purine nucleotides in plants as well as other organisms. Small nucleoside-3′-monophosphate (3′-nucleotides) pools are mainly produced as catabolites of nucleic acids. Examples of different forms of nucleotides are adenosine-5′-monophosphate (5′-AMP, usually abbreviated as AMP) (23), adenosine-3′-monophosphate (3′-AMP) (24), deoxyadenosine-5′-monophosphate (dAMP) (25), and isopentenyladenine ribotide (26).
The cyclic monophosphates, cyclic adenosine-3′,5′-monophosphate (cAMP) (27) and cyclic guanosine-3′,5′-monophosphate (cGMP) occur in plants. These cyclic nucleotides are derived from ATP and GTP and act as second messengers. In addition, some unusual nucleotides, such as guanosine tetraphosphate (ppGpp), guanosine pentaphosphate (pppGpp) (28), diadenosine triphosphate (Ap3A), and diadenosine tetraphosphate (Ap4A), known as alarmones, which act as intracellular signal molecules, are produced in response to harsh environmental conditions (Boniecka et al. 2017; Pietrowska-Borek et al. 2011). Possible roles of these unusual nucleotides in plants are outlined in Part VIII.
Pyrimidine (29) is an aromatic heterocyclic organic compound similar to pyridine. The systematic study of pyrimidines was carried out and named ‘pyrimidin’ by a German chemist, Adolf Pinner (1885).
Uracil (30), cytosine (31), and thymine (32) are the common nucleobases of nucleic acids. DNA and RNA also contain other bases that have been modified after formation of the nucleic acid chain. In the case of DNA, the most common modified base is 5-methylcytosine (33).
Orotate (pyrimidine carboxylic acid) (34) is an intermediate of the de novo pyrimidine biosynthesis. A number of secondary products, such as 5-aminouracil (35), lathyrine (36), and willardine (37) occur in plants (see Part VIII). Dihydrouracil (38) is an intermediate of uracil catabolism (see Part III).
A pyrimidine nucleoside consists of a pyrimidine base and a five-carbon sugar, either ribose or deoxyribose. Uridine (39) and cytidine (40) are produced as catabolites of pyrimidine ribonucleotides and RNA. Thymidine (41) is a catabolite of DNA. There are many modified bases in RNA, including those contained in the nucleosides, pseudouridine (5-ribosyluracil) (42), and dihydrouridine (43). Pseudouridine is an isomer of the nucleoside uridine (39) in which the uracil is attached via a carbon–carbon linkage instead of a nitrogen–carbon glycosidic bond. It is the most prevalent of the over 100 different modified nucleosides found in RNA.
A pyrimidine nucleotide is composed of a pyrimidine base, a sugar (ribose or deoxyribose) and at least a phosphate group. Examples of different forms of pyrimidine nucleotide structures are uridine-5′-monophosphate (5′-UMP usually abbreviated as UMP) (44) and orotidine-5′-monophosphate (5′-OMP) (45), an intermediate of the de novo pyrimidine biosynthesis.
Pyridine (46) is a basic heterocyclic organic compound. It is structurally related to benzene, with one methine group replaced by a nitrogen atom, and was discovered in 1849 by a Scottish chemist, Thomas Anderson, as one of the constituents of bone oil. Pyridine-related compounds include the catabolites nicotinate (47) and nicotinamide (48), and quinolinate (49) and NMN (50), which are intermediates of the biosynthesis of NAD (51) and NADP. These compounds act as common coenzymes involved in many redox reactions, carrying electrons from one reaction to another in all living cells. Each coenzyme consists of pyridine purine nucleotides joined through their phosphate groups. NAD(P) exists in two forms: an oxidized and reduced form abbreviated as NAD(P)+ and NAD(P)H respectively.
Nomenclature and abbreviations of nucleotide-related compounds and major chemical structures of purines, pyrimidine, and pyridine are described.